The 25 country report has led to the creation of the International Neuroblastoma Risk Group Classification System, with the results published in two papers in the Journal of Clinical Oncology today.
Professor Pearson, alongside co-author Professor Susan Cohn at the University of Chicago are extremely optimistic about improving standards of care for all neuroblastoma patients. Professor Andrew Pearson comments:
“This tailored strategy will hopefully replace the existing ‘one size fits all’ approach utilised across the world. It streamlines the process for identifying what stage the disease is at and how aggressive it is, and clearly identifies how much treatment each child should receive.”
“In this way, we hope that children with neuroblastoma will receive the best possible chance of a cure, keeping the level of treatment and the associated side-effects to a minimum.”
The new strategy will be used by the International Neuroblastoma Risk Group (INRG) which represents paediatric oncologists treating neuroblastoma patients treated in Europe, Japan, the USA, Canada, and Australia.
Survival rates overall for children with cancer have improved dramatically in recent years. However, more than half of children with neuroblastoma will present the aggressive, high-risk disease, which is more likely to relapse and is linked with a poor rate of recovery.
“How neuroblastoma attacks the body varies dramatically in each patient and, up until now, it has been difficult to accurately predict the progression of the disease. With these systems, we will be able to choose appropriate treatments based on the evidence of relevant risk factors.” Professor Pearson says.
Neuroblastoma, a cancer of the developing nervous system, is one of the most common types of childhood cancers, causing 15 per cent of all childhood cancer deaths in the UK. Its different forms vary in severity: while some cases in young children disappear with minimal treatment, cases in older children can be relentlessly aggressive. Identifying the form is therefore crucial in planning appropriate treatment.
Bethany Hankin was diagnosed with aggressive neuroblastoma aged 18 months. Now 3 years old and in remission, her mother Katie Hankin is eager to see better information for doctors:
“The harsh reality is that neuroblastoma is one of the most aggressive childhood cancers, yet receives very little attention. During Bethany’s first course of treatment, we had been told parts of her diagnosis, but not the exact status of her disease. Neuroblastoma is such an unpredictable disease, any research that helps doctors make a more informed diagnosis sooner can only be a blessing for families.”
This new research was funded by the William Guy Forbeck Research Foundation and Little Heroes Paediatric Cancer Research Foundation, and offers clearer direction for diagnosis and risk assessment for clinicians on a global level.
The first of the two papers proposes the International Neuroblastoma Risk Group (INRG) classification system. The paper focuses on the personalisation of treatment by classifying neuroblastoma based on 13 factors.
The second paper replaces the current four stage system of diagnosis of neuroblastoma based on a new International Neuroblastoma Risk Group Staging System (INRGSS.)
New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
29.05.2017 | Earth Sciences
29.05.2017 | Life Sciences
29.05.2017 | Physics and Astronomy